FORTUNE NAMES TRANSWESTERN ONE OF THE “BEST WORKPLACES IN TEXAS” FOR SECOND YEAR
Mar 20, 2018 21:41 pm UTC| Business
HOUSTON, March 20, 2018 -- Transwestern today announces Great Place to Work® and Fortune magazine have named it one of the “2018 Best Workplaces in Texas.” This marks the second year in a row the commercial real estate...
DiaMedica Therapeutics Announces Closing of Private Placement
Mar 20, 2018 21:40 pm UTC| Business
MINNEAPOLIS, March 20, 2018 -- DiaMedica Therapeutics Inc. (the “Company”) (TSX-V:DMA) (OTCQB:DMCAF) is pleased to announce the successful completion of the first closing of a private placement for aggregate gross...
Ambev’s 2017 Annual Report on Form 20-F Available on Our Website
Mar 20, 2018 21:30 pm UTC| Business
SO PAULO, Brazil, March 20, 2018 -- Ambev S.A. (B3:ABEV3) (NYSE:ABEV) announces that the Company‘s annual report on Form 20-F for the year ended December 31, 2017 was filed with the U.S. Securities and Exchange...
Mar 20, 2018 21:25 pm UTC| Business
Chicago, Illinois, March 20, 2018 -- The John Marshall Law School’s Legal Writing, Trial Advocacy and Intellectual Property Law programs have been ranked among the nation’s best in the 2019 U.S. News World Report’s...
Front Yard Residential Corporation Announces Quarterly Cash Dividend
Mar 20, 2018 21:18 pm UTC| Business
CHRISTIANSTED, U.S. Virgin Islands, March 20, 2018 -- Front Yard Residential Corporation (“Front Yard” or the “Company”) (NYSE:RESI) announced today that its Board of Directors has declared a quarterly cash dividend...
ScottMadden Announces Promotion of Andy Flores to Corporate Practice Leader
Mar 20, 2018 21:07 pm UTC| Business
Atlanta, GA, March 20, 2018 -- ScottMadden, Inc., a general management consulting firm, is pleased to announce the promotion of Andy Flores to Corporate Practice Leader. As of January 1, Mr. Flores has taken this new...
Immunovaccine Announces Year-End 2017 Financial Results
Mar 20, 2018 21:05 pm UTC| Business
HALIFAX, Nova Scotia, March 20, 2018 -- Immunovaccine Inc. (TSX:IMV) (OTCQX:IMMVF), a clinical stage immuno-oncology corporation, today released its financial and operational results for the fiscal year ended December...